|
US2065593A
(en)
|
|
1936-12-29 |
|
Water-soluble diazoimino com |
|
FR472489A
(fr)
|
1914-02-20 |
1914-12-08 |
Stas Motor Ges M B H |
Bague de garniture métallique pour pistons
|
|
US2065900A
(en)
|
1935-03-23 |
1936-12-29 |
Gen Aniline Works Inc |
Dihydroxystilbene-dicarboxylic acid and a process of preparing it
|
|
US2071329A
(en)
|
1935-08-22 |
1937-02-23 |
Solvay Process Co |
Method of recovering phthalic anhydride
|
|
GB728767A
(en)
|
1951-10-12 |
1955-04-27 |
Wander Ag Dr A |
2-substituted chromone compounds, and a method of making same
|
|
US3251837A
(en)
|
1962-09-14 |
1966-05-17 |
Pfizer & Co C |
Derivatives of 1, 2, 4-benzothiadiazine-1, 1-dioxides
|
|
GB1179019A
(en)
|
1967-05-23 |
1970-01-28 |
Produits Chimique Soc Et |
Polynicotinic Esters of Flavonoids
|
|
FR6928M
(enExample)
|
1967-11-24 |
1969-05-05 |
|
|
|
US3600394A
(en)
|
1968-05-17 |
1971-08-17 |
Searle & Co |
2-aminoalkyl-3-arylisocarbostyrils
|
|
US3773946A
(en)
|
1969-09-02 |
1973-11-20 |
Parke Davis & Co |
Triglyceride-lowering compositions and methods
|
|
US3930024A
(en)
|
1969-09-02 |
1975-12-30 |
Parke Davis & Co |
Pharmaceutical compositions and methods
|
|
FR2244493A1
(en)
|
1973-08-09 |
1975-04-18 |
Pluripharm |
Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis
|
|
DE2349024A1
(de)
|
1973-09-26 |
1975-04-10 |
Schering Ag |
6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione
|
|
IT1050750B
(it)
|
1975-12-05 |
1981-03-20 |
Erba Carlo Spa |
Derivati della 3.4 di idro chinazolina
|
|
US4159330A
(en)
|
1976-11-02 |
1979-06-26 |
Carlo Erba S.P.A. |
2-Disubstituted phenyl-3,4-dihydro-4-oxo-quinazoline derivatives and process for their preparation
|
|
US5098903A
(en)
|
1980-03-07 |
1992-03-24 |
Board Of Regents Of The University Of Oklahoma |
Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents
|
|
IL64542A0
(en)
|
1981-12-15 |
1982-03-31 |
Yissum Res Dev Co |
Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
|
JPS60136512A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
脂質代謝改善剤
|
|
DE3423166A1
(de)
|
1984-06-22 |
1986-01-02 |
Epis S.A., Zug |
Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
|
CA1281720C
(en)
|
1984-11-08 |
1991-03-19 |
Makoto Sunagawa |
Carbapenem compounds and production thereof
|
|
DE3515882A1
(de)
|
1985-05-03 |
1986-11-06 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Arzneimittel, enthaltend pyridinone mit antithrombotischen wirkungen und verfahren zu ihrer herstellung
|
|
DE3532279A1
(de)
|
1985-09-11 |
1987-03-12 |
Bayer Ag |
1,4-benzoxathiin-derivate
|
|
DE3601417A1
(de)
|
1986-01-20 |
1987-07-23 |
Nattermann A & Cie |
2'-alkyl-(alkenyl-) substituierte quercetine
|
|
US4825005A
(en)
|
1986-08-29 |
1989-04-25 |
Ciba-Geigy Corporation |
Process for the preparation of aromatic ether and thioether compounds
|
|
ES2053508T3
(es)
|
1986-11-24 |
1994-08-01 |
Fujisawa Pharmaceutical Co |
Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
|
|
GB8804058D0
(en)
|
1988-02-22 |
1988-03-23 |
Fujisawa Pharmaceutical Co |
3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds
|
|
US4925838A
(en)
|
1988-03-18 |
1990-05-15 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
|
US4963544A
(en)
|
1988-05-23 |
1990-10-16 |
Fujisawa Pharmaceutical Company, Ltd. |
3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
|
|
GB8926981D0
(en)
|
1988-12-23 |
1990-01-17 |
Ici Plc |
Heterocyclic derivatives
|
|
IE902465A1
(en)
|
1989-07-07 |
1991-02-13 |
Schering Corp |
Pharmaceutically active compounds
|
|
FR2649612A1
(fr)
|
1989-07-17 |
1991-01-18 |
Rhone Poulenc Sante |
Medicaments a base de derives de 1h-benzoxadiazine-4,1,2 nouveaux derives et leurs procedes de preparation
|
|
IE64358B1
(en)
|
1989-07-18 |
1995-07-26 |
Ici Plc |
Diaryl ether heterocycles
|
|
GB9018134D0
(en)
|
1989-09-29 |
1990-10-03 |
Ici Plc |
Heterocyclic derivatives
|
|
CA2224047A1
(en)
|
1990-06-05 |
1991-12-06 |
Toray Industries, Inc. |
Indole derivatives
|
|
JP2999579B2
(ja)
|
1990-07-18 |
2000-01-17 |
武田薬品工業株式会社 |
Ｄｎａおよびその用途
|
|
GB9025832D0
(en)
|
1990-11-28 |
1991-01-09 |
Ashwell Geoffrey J |
Novel films for nonlinear optical applications
|
|
IE913866A1
(en)
|
1990-11-28 |
1992-06-03 |
Ici Plc |
Aryl derivatives
|
|
US5126351A
(en)
|
1991-01-24 |
1992-06-30 |
Glaxo Inc. |
Antitumor compounds
|
|
MX9200299A
(es)
|
1991-02-07 |
1992-12-01 |
Roussel Uclaf |
Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
|
|
AU1746392A
(en)
|
1991-04-10 |
1992-11-17 |
Octamer, Inc. |
A method for inhibition of retroviral replication
|
|
AU658646B2
(en)
|
1991-05-10 |
1995-04-27 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
US5124337A
(en)
|
1991-05-20 |
1992-06-23 |
Schering Corporation |
N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase
|
|
US5223506A
(en)
|
1991-06-04 |
1993-06-29 |
Glaxo Inc. |
Cyclic antitumor compounds
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
US5250679A
(en)
|
1991-10-18 |
1993-10-05 |
Genentech, Inc. |
Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
|
|
GB9126260D0
(en)
|
1991-12-11 |
1992-02-12 |
Pfizer Ltd |
Therapeutic agents
|
|
US5474994A
(en)
|
1992-05-26 |
1995-12-12 |
Recordati S.A., Chemical And Pharmaceutical Company |
Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
|
|
FR2689127B1
(fr)
|
1992-03-31 |
1994-05-06 |
Adir Cie |
Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
|
|
US7655699B1
(en)
|
1992-04-22 |
2010-02-02 |
Eisai Inc. |
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
|
|
DE4215588A1
(de)
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Biphenylmethyl-substituierte Pyridone
|
|
DE4215587A1
(de)
|
1992-05-12 |
1993-11-18 |
Bayer Ag |
Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone
|
|
GB9218334D0
(en)
|
1992-08-28 |
1992-10-14 |
Ici Plc |
Heterocyclic compounds
|
|
JPH0680656A
(ja)
|
1992-09-03 |
1994-03-22 |
Mitsui Petrochem Ind Ltd |
光学活性エポキシドの製造方法
|
|
WO1994014763A1
(en)
|
1992-12-23 |
1994-07-07 |
Procept, Inc. |
Novel agents for inhibition of hiv infectivity and use therefor
|
|
JPH0741442A
(ja)
|
1993-05-21 |
1995-02-10 |
Sumitomo Chem Co Ltd |
アセチレンアルコール誘導体およびその製造法
|
|
JPH0761942A
(ja)
|
1993-06-17 |
1995-03-07 |
Sumitomo Chem Co Ltd |
フェノール誘導体およびその製造法
|
|
JPH0725761A
(ja)
|
1993-07-09 |
1995-01-27 |
Kureha Chem Ind Co Ltd |
軟骨保護剤
|
|
US5756763A
(en)
|
1993-07-23 |
1998-05-26 |
Zaidan Hojin Biseibutsu Kagaku Kenkyukai |
Pyrrolidine derivatives
|
|
US5707547A
(en)
|
1993-08-03 |
1998-01-13 |
Sumitomo Chemical Company, Limited |
Trans-olefin compounds, method for production thereof, liquid crystal composition containing the same as active ingredient, and liquid crystal element using said composition
|
|
JPH07118241A
(ja)
|
1993-09-01 |
1995-05-09 |
Sumitomo Chem Co Ltd |
フェノール誘導体およびその製造法
|
|
JPH07179380A
(ja)
|
1993-12-22 |
1995-07-18 |
Sumitomo Chem Co Ltd |
アルコール誘導体およびその製造法
|
|
JPH07233109A
(ja)
|
1994-02-24 |
1995-09-05 |
Sumitomo Chem Co Ltd |
光学活性なアルコール誘導体およびその製造法
|
|
US5707987A
(en)
|
1994-02-25 |
1998-01-13 |
Banyu Pharmaceutical Co., Ltd. |
Carbapenem derivatives
|
|
WO1995024410A1
(en)
|
1994-03-08 |
1995-09-14 |
Otsuka Pharmaceutical Factory, Inc. |
Phosphonic diester derivative
|
|
JPH07247289A
(ja)
|
1994-03-11 |
1995-09-26 |
Mitsui Petrochem Ind Ltd |
クロメンオキシド類の製造方法
|
|
FR2718329B1
(fr)
|
1994-03-21 |
2002-09-20 |
Rhone Poulenc Rorer Sa |
Lapin transgénique sensibilisé aux dyslipoprotéinémies.
|
|
US6048903A
(en)
|
1994-05-03 |
2000-04-11 |
Robert Toppo |
Treatment for blood cholesterol with trans-resveratrol
|
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
GB2292149A
(en)
|
1994-08-09 |
1996-02-14 |
Ferring Res Ltd |
Peptide inhibitors of pro-interleukin-1beta converting enzyme
|
|
JP3702493B2
(ja)
|
1994-08-12 |
2005-10-05 |
大正製薬株式会社 |
キナゾリン−４（３ｈ）−オン誘導体
|
|
RU2191188C2
(ru)
|
1994-11-14 |
2002-10-20 |
Варнер-Ламберт Компани |
Производные 6-арилпиридо[2,3-d]-пиримидины и -нафтиридины, фармацевтическая композиция, обладающая ингибирующим действием клеточной пролиферации, вызываемой протеиновой тирозинкиназой, и способ ингибирования клеточной пролиферации
|
|
IL115256A0
(en)
|
1994-11-14 |
1995-12-31 |
Warner Lambert Co |
6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
|
|
US5446071A
(en)
|
1994-11-18 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
|
JP4140981B2
(ja)
|
1994-12-26 |
2008-08-27 |
東菱薬品工業株式会社 |
再狭窄症及び動脈硬化症治療薬
|
|
US5648387A
(en)
|
1995-03-24 |
1997-07-15 |
Warner-Lambert Company |
Carboxyalkylethers, formulations, and treatment of vascular diseases
|
|
WO1996031206A2
(en)
|
1995-04-07 |
1996-10-10 |
Warner-Lambert Company |
Flavones and coumarins as agents for the treatment of atherosclerosis
|
|
ES2180702T3
(es)
|
1995-06-07 |
2003-02-16 |
Lilly Co Eli |
Tratamiento de patologias por la induccion del factor de transcripcion bef-1.
|
|
WO1997008153A1
(en)
|
1995-08-30 |
1997-03-06 |
Otsuka Pharmaceutical Factory, Inc. |
Process for producing quinazolin-4-one derivatives
|
|
US5783577A
(en)
|
1995-09-15 |
1998-07-21 |
Trega Biosciences, Inc. |
Synthesis of quinazolinone libraries and derivatives thereof
|
|
WO1997010221A1
(en)
|
1995-09-15 |
1997-03-20 |
Torrey Pines Institute For Molecular Studies |
Synthesis of quinazolinone libraries
|
|
HUP9802319A3
(en)
|
1995-10-23 |
1999-12-28 |
Zymogenetics Inc Seattle |
Pharmaceutical compositions for treatment of bone deficit conditions
|
|
HU224225B1
(hu)
|
1995-12-01 |
2005-06-28 |
Sankyo Co. Ltd. |
Tachikinin receptor antagonista hatású heterociklusos vegyületek, ezek előállítási eljárása és alkalmazásuk gyógyszerkészítmények előállítására
|
|
US5756736A
(en)
|
1996-01-26 |
1998-05-26 |
Syntex (U.S.A.) Inc. |
Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
|
|
WO1997028118A1
(en)
|
1996-02-05 |
1997-08-07 |
Hoechst Celanese Corporation |
Process for preparing anthranilic acids
|
|
US5739330A
(en)
|
1996-02-05 |
1998-04-14 |
Hoechst Celanese Corporation |
Process for preparing quinazolones
|
|
US5763608A
(en)
|
1996-02-05 |
1998-06-09 |
Hoechst Celanese Corporation |
Process for preparing pyrimidine derivatives
|
|
KR19990082488A
(ko)
|
1996-02-12 |
1999-11-25 |
루트거스, 더 스테이트 유니버시티 오브 뉴 저지 |
토포이소머라제 억제제로서의 코르알린 동족체
|
|
BR9711805A
(pt)
|
1996-06-20 |
2002-01-15 |
Regents The Univesity Of Texas |
Compostos e métodos para providenciar preparações farmacologicamente ativas e uso dos mesmos
|
|
US5854264A
(en)
|
1996-07-24 |
1998-12-29 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
KR100213895B1
(ko)
|
1996-10-14 |
1999-08-02 |
박원훈 |
감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물
|
|
DE19651099A1
(de)
|
1996-12-09 |
1998-06-10 |
Consortium Elektrochem Ind |
Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung
|
|
IL119971A
(en)
|
1997-01-07 |
2003-02-12 |
Yissum Res Dev Co |
Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
|
|
JPH10287678A
(ja)
|
1997-04-11 |
1998-10-27 |
Kyowa Hakko Kogyo Co Ltd |
ピラノアジン誘導体
|
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
|
US5908861A
(en)
|
1997-05-13 |
1999-06-01 |
Octamer, Inc. |
Methods for treating inflammation and inflammatory disease using pADPRT inhibitors
|
|
EP1009404A4
(en)
|
1997-05-13 |
2009-07-01 |
Octamer Inc |
PROCESS FOR TREATING INFLAMMATION OR INFLAMMATORY DISEASES USING POLY-ADP RIBOSE POLYMERASE INHIBITORS
|
|
DE69807222T2
(de)
|
1997-06-02 |
2003-04-17 |
Janssen Pharmaceutica N.V., Beerse |
(imidazol-5-yl)methyl-2-quinolinone derivativen als inhibitoren von proliferation der glatten muskelzellen
|
|
IL121165A0
(en)
|
1997-06-26 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical compositions containing carboxylic acids and derivatives thereof
|
|
AU8885498A
(en)
|
1997-08-29 |
1999-03-22 |
Takeda Chemical Industries Ltd. |
Triazine derivatives, their production and use
|
|
US20020022636A1
(en)
|
1997-09-03 |
2002-02-21 |
Jia-He Li |
Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
|
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
|
US6239114B1
(en)
|
1997-09-26 |
2001-05-29 |
Kgk Synergize |
Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
|
|
WO1999018077A1
(en)
|
1997-10-02 |
1999-04-15 |
Eisai Co., Ltd. |
Fused pyridine derivatives
|
|
JP2001520992A
(ja)
|
1997-10-28 |
2001-11-06 |
コリア インスティテュート オブ サイエンス アンド テクノロジー |
アシルｃｏａ−コレステロール−ｏ−アシルトランスフェラーゼ抑制剤、動脈壁上でのマクロファージ−脂質複合体蓄積の抑制剤および肝疾患予防または治療剤としてのナリンジンおよびナリンゲニン
|
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
|
DE19756388A1
(de)
|
1997-12-18 |
1999-06-24 |
Hoechst Marion Roussel De Gmbh |
Substituierte 2-Aryl-4-amino-chinazoline
|
|
US6512161B1
(en)
|
1998-01-08 |
2003-01-28 |
Aventis Pharmaceuticals, Inc. |
Transgenic rabbit that expresses a functional human lipoprotein (a)
|
|
US6414037B1
(en)
|
1998-01-09 |
2002-07-02 |
Pharmascience |
Pharmaceutical formulations of resveratrol and methods of use thereof
|
|
HU225539B1
(en)
|
1998-03-17 |
2007-02-28 |
Chugai Pharmaceutical Co Ltd |
Preventives or remedies for inflammatory intestinal diseases containing as the active ingredient antibody against il-6 receptor
|
|
US6022901A
(en)
|
1998-05-13 |
2000-02-08 |
Pharmascience Inc. |
Administration of resveratrol to prevent or treat restenosis following coronary intervention
|
|
WO2000010607A1
(en)
|
1998-08-24 |
2000-03-02 |
Chugai Seiyaku Kabushiki Kaisha |
Preventives or remedies for pancreatitis containing il-6 antagonists as the active ingredient
|
|
SE9802973D0
(sv)
|
1998-09-03 |
1998-09-03 |
Astra Ab |
Immediate release tablet
|
|
KR20010079922A
(ko)
|
1998-09-24 |
2001-08-22 |
미우라 아키라 |
하이드록시플라본 유도체
|
|
CN1148188C
(zh)
|
1998-10-19 |
2004-05-05 |
卫材株式会社 |
镇痛剂
|
|
CN1327384A
(zh)
|
1998-10-20 |
2001-12-19 |
韩国科学技术研究院 |
作为血浆高密度脂蛋白浓度增高剂的生物类黄酮
|
|
AU2190700A
(en)
|
1998-12-17 |
2000-07-03 |
Tularik Inc. |
Tubulin-binding agents
|
|
US6291456B1
(en)
|
1998-12-30 |
2001-09-18 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
|
US6399633B1
(en)
|
1999-02-01 |
2002-06-04 |
Aventis Pharmaceuticals Inc. |
Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
|
|
TR200102522T2
(tr)
|
1999-03-15 |
2001-12-21 |
Abbott Laboratories |
Antibakteryel etkinliğe sahip olan 6-0-ikameli makrolidler.
|
|
US6969720B2
(en)
|
1999-03-17 |
2005-11-29 |
Amr Technology, Inc. |
Biaryl substituted purine derivatives as potent antiproliferative agents
|
|
US6054435A
(en)
|
1999-03-19 |
2000-04-25 |
Abbott Laboratories |
6-O-substituted macrolides having antibacterial activity
|
|
EP1177187B1
(en)
|
1999-04-28 |
2007-07-25 |
Sanofi-Aventis Deutschland GmbH |
Di-aryl acid derivatives as ppar receptor ligands
|
|
US6835755B1
(en)
|
1999-06-24 |
2004-12-28 |
University Of Pretoria |
Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
|
|
DE19934799B4
(de)
|
1999-07-28 |
2008-01-24 |
Az Electronic Materials (Germany) Gmbh |
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
|
|
JP2001131151A
(ja)
|
1999-11-02 |
2001-05-15 |
Shionogi & Co Ltd |
オレフィン誘導体の新規用途
|
|
JP5278983B2
(ja)
|
1999-11-17 |
2013-09-04 |
塩野義製薬株式会社 |
アミド化合物の新規用途
|
|
CA2393297C
(en)
|
1999-12-06 |
2010-10-05 |
Welichem Biotech Inc. |
Polyhydroxystilbenes as antipsoriatic agents and protein kinase inhibitors
|
|
FR2804679B1
(fr)
|
2000-02-07 |
2002-04-26 |
Clariant France Sa |
Nouveaux composes phenoliques derives des dialcoxyethanals, leur procede de preparation et leur application
|
|
ATE272600T1
(de)
|
2000-02-17 |
2004-08-15 |
Appleton Paper Inc |
Verfahren zur herstellung von alkoxy- oder arylmethoxy-aroxyethanen
|
|
CN100345830C
(zh)
|
2000-04-27 |
2007-10-31 |
安斯泰来制药有限公司 |
稠合杂芳基衍生物
|
|
WO2001082916A2
(en)
|
2000-05-03 |
2001-11-08 |
Tularik Inc. |
Combination therapeutic compositions and methods of use
|
|
US6548694B2
(en)
|
2000-05-23 |
2003-04-15 |
Hoffman-La Roche Inc. |
N-(4-carbamimidoyl-phenyl)-glycine derivatives
|
|
JP2001335476A
(ja)
|
2000-05-29 |
2001-12-04 |
Shionogi & Co Ltd |
三環化合物の新規用途
|
|
US6479499B1
(en)
|
2000-06-28 |
2002-11-12 |
National Science Council |
2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
|
|
US20020025301A1
(en)
|
2000-07-04 |
2002-02-28 |
Sylke Haremza |
Novel flavonoids and their use in cosmetic and dermatological preparations
|
|
US6541522B2
(en)
|
2000-08-16 |
2003-04-01 |
Insmed Incorporated |
Methods of using compositions containing hypotriglyceridemically active stilbenoids
|
|
US7723303B2
(en)
|
2000-08-24 |
2010-05-25 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
AU2001296502B2
(en)
|
2000-10-02 |
2005-06-09 |
Molecular Probes, Inc. |
Reagents for labeling biomolecules having aldehyde or ketone moieties
|
|
CA2356544C
(en)
|
2000-10-03 |
2006-04-04 |
Warner-Lambert Company |
Pyridotriazines and pyridopyridazines
|
|
WO2002028835A1
(en)
|
2000-10-05 |
2002-04-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzamide compounds as apo b secretion inhibitors
|
|
EP1363879A2
(en)
|
2000-10-11 |
2003-11-26 |
Esperion Therapeutics Inc. |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
|
AU2002211667A1
(en)
|
2000-10-11 |
2002-04-22 |
Esperion Therapeutics, Inc. |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
|
SK4772003A3
(en)
|
2000-10-19 |
2003-08-05 |
Merck & Co Inc |
Estrogen receptor modulators
|
|
AU2002222566A1
(en)
|
2000-11-30 |
2002-06-11 |
Canon Kabushiki Kaisha |
Luminescent element and display
|
|
WO2002046172A2
(en)
|
2000-12-07 |
2002-06-13 |
Cv Therapeutics, Inc. |
Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
|
|
KR100472694B1
(ko)
|
2000-12-30 |
2005-03-07 |
한국생명공학연구원 |
플라바논 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물
|
|
JP2002249483A
(ja)
|
2001-02-21 |
2002-09-06 |
Koei Chem Co Ltd |
アリール置換複素環式化合物の製造法
|
|
JP4256679B2
(ja)
|
2001-03-16 |
2009-04-22 |
ノボゲン リサーチ ピーティーワイ リミテッド |
再狭窄の治療方法
|
|
EP1385501A2
(en)
|
2001-04-11 |
2004-02-04 |
Atherogenics, Inc. |
Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
|
|
EP1397137B1
(en)
|
2001-05-25 |
2009-10-14 |
Bristol-Myers Squibb Company |
Hydantion derivatives as inhibitors of matrix metalloproteinases
|
|
US20030211086A1
(en)
*
|
2001-06-05 |
2003-11-13 |
Neil Berkley |
Minicell-based selective absorption
|
|
WO2003007959A1
(en)
|
2001-07-16 |
2003-01-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinoxaline derivatives which have parp inhibitory action
|
|
GB0118752D0
(en)
|
2001-08-01 |
2001-09-26 |
Pfizer Ltd |
Process for the production of quinazolines
|
|
US7173128B2
(en)
|
2001-08-13 |
2007-02-06 |
Ciba Specialty Chemicals Corporation |
Ultraviolet light absorbers
|
|
EP1419770A4
(en)
|
2001-08-24 |
2005-08-03 |
Shionogi & Co |
AGENT ACC L RATION OF THE EXPRESSION OF APO AI
|
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
|
EP1426046A4
(en)
|
2001-09-14 |
2005-11-02 |
Shionogi & Co |
NEW USE OF TRICYCLIC COMPOUNDS
|
|
US7429593B2
(en)
|
2001-09-14 |
2008-09-30 |
Shionogi & Co., Ltd. |
Utilities of amide compounds
|
|
US6835469B2
(en)
|
2001-10-17 |
2004-12-28 |
The University Of Southern California |
Phosphorescent compounds and devices comprising the same
|
|
US7250512B2
(en)
|
2001-11-07 |
2007-07-31 |
E. I. Du Pont De Nemours And Company |
Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
|
|
US7166368B2
(en)
|
2001-11-07 |
2007-01-23 |
E. I. Du Pont De Nemours And Company |
Electroluminescent platinum compounds and devices made with such compounds
|
|
US6541045B1
(en)
|
2002-01-04 |
2003-04-01 |
Nutraceutical Corporation |
Herbal composition and method for combating inflammation
|
|
US8367824B2
(en)
|
2002-01-28 |
2013-02-05 |
Ube Industries Ltd. |
Process for producing quinazolin-4-one derivative
|
|
JP2005529850A
(ja)
|
2002-02-19 |
2005-10-06 |
ファルマシア・イタリア・エス・ピー・エー |
三環系ピラゾール誘導体、その製造方法および抗腫瘍剤としてのその使用
|
|
GB0206033D0
(en)
|
2002-03-14 |
2002-04-24 |
Pfizer Ltd |
Compounds useful in therapy
|
|
NZ556545A
(en)
|
2002-03-22 |
2009-03-31 |
Novartis Ag |
Combination comprising a beta-hydroxy-beta-methylglutaryl-co-enzyme-A reductase inhibitor and a glucagon-like peptide-1 agonist
|
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
|
TW200401770A
(en)
|
2002-06-18 |
2004-02-01 |
Sankyo Co |
Fused-ring pyrimidin-4(3H)-one derivatives, processes for the preparation and uses thereof
|
|
KR20040001144A
(ko)
|
2002-06-27 |
2004-01-07 |
김대경 |
신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법
|
|
US20050080021A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
|
|
US20040033480A1
(en)
|
2002-08-15 |
2004-02-19 |
Wong Norman C.W. |
Use of resveratrol to regulate expression of apolipoprotein A1
|
|
US20050080024A1
(en)
|
2002-08-15 |
2005-04-14 |
Joseph Tucker |
Nitric oxide donating derivatives for the treatment of cardiovascular disorders
|
|
AU2003265659A1
(en)
|
2002-08-23 |
2004-03-11 |
University Of Connecticut |
Novel biphenyl and biphenyl-like cannabinoids
|
|
WO2004019933A1
(en)
|
2002-08-30 |
2004-03-11 |
Pharmacia & Upjohn Company |
Method of preventing or treating atherosclerosis or restenosis
|
|
EP1407774A1
(en)
|
2002-09-10 |
2004-04-14 |
LION Bioscience AG |
2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
|
|
EP1398032A1
(en)
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxo-quinazolines as LXR nuclear receptor binding compounds
|
|
AU2003284001A1
(en)
|
2002-10-07 |
2004-05-04 |
Bristol-Myers Squibb Company |
Triazolone and triazolethione derivatives
|
|
WO2004037176A2
(en)
|
2002-10-21 |
2004-05-06 |
Bristol-Myers Squibb Company |
Quinazolinones and derivatives thereof as factor xa inhibitors
|
|
WO2004039795A2
(en)
|
2002-10-29 |
2004-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds for the treatment of hyperlipidemia
|
|
AU2003291761A1
(en)
|
2002-11-04 |
2004-06-07 |
Nps Pharmaceuticals, Inc. |
Quinazolinone compounds as calcilytics
|
|
EP1418164A1
(en)
|
2002-11-07 |
2004-05-12 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists
|
|
ATE427951T1
(de)
|
2002-11-18 |
2009-04-15 |
Hoffmann La Roche |
Diazinopyrimidine und ihre verwendung als proteinkinaseinhibitoren
|
|
AU2003293006A1
(en)
|
2002-11-22 |
2004-06-18 |
Japan Tobacco Inc. |
Fused bicyclic nitrogen-containing heterocycles
|
|
MXPA05006124A
(es)
|
2002-12-13 |
2005-08-16 |
Hoffmann La Roche |
Derivados de 3-quinazolin-4-ona.
|
|
ITRM20020629A1
(it)
|
2002-12-19 |
2004-06-20 |
Sigma Tau Ind Farmaceuti |
Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
|
|
ATE496893T1
(de)
|
2002-12-20 |
2011-02-15 |
X Ceptor Therapeutics Inc |
Isochinolinonderivate und deren verwendung als medikamente
|
|
JP2004203751A
(ja)
|
2002-12-24 |
2004-07-22 |
Pfizer Inc |
置換６，６−ヘテロ二環式誘導体
|
|
WO2004058682A1
(ja)
|
2002-12-26 |
2004-07-15 |
Eisai Co., Ltd. |
選択的エストロゲン受容体モジュレーター
|
|
WO2004065392A1
(en)
|
2003-01-24 |
2004-08-05 |
Smithkline Beecham Corporation |
Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
|
|
WO2004072042A2
(en)
|
2003-02-12 |
2004-08-26 |
Carex S.A. |
Quinoline derivative and their use for modulation of lxr activity
|
|
US7547794B2
(en)
|
2003-04-03 |
2009-06-16 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
|
JP4895806B2
(ja)
|
2003-04-09 |
2012-03-14 |
エクセリクシス， インク． |
Ｔｉｅ−２モジュレータと使用方法
|
|
JP2004307440A
(ja)
|
2003-04-10 |
2004-11-04 |
Kyorin Pharmaceut Co Ltd |
２−アミノ‐１，３‐プロパンジオール誘導体とその付加塩
|
|
EP1629000B1
(en)
|
2003-04-16 |
2009-02-18 |
Bristol-Myers Squibb Company |
Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus
|
|
EP1631295B1
(en)
|
2003-06-06 |
2010-03-03 |
Arexis AB |
Use of condensed heterocyclic compounds as scce inhibitors for the treatment of skin diseases
|
|
US7314939B2
(en)
|
2003-06-17 |
2008-01-01 |
Millennium Pharmaceuticals, Inc. |
Compositions and methods for inhibiting TGF-β
|
|
WO2004113307A1
(ja)
|
2003-06-18 |
2004-12-29 |
Ube Industries, Ltd. |
ピリミジン−４−オン化合物の製造方法
|
|
US20050043300A1
(en)
|
2003-08-14 |
2005-02-24 |
Pfizer Inc. |
Piperazine derivatives
|
|
US20050096391A1
(en)
|
2003-10-10 |
2005-05-05 |
Per Holm |
Compositions comprising fenofibrate and rosuvastatin
|
|
KR20060120101A
(ko)
|
2003-10-10 |
2006-11-24 |
리스버로직스 코퍼레이션 |
Ｅｇｒ-1 인핸서 요소와 관련된 질환의 치료
|
|
EP1678157A4
(en)
|
2003-10-28 |
2009-03-18 |
Reddy Us Therapeutics Inc |
Heterocyclic compounds and process for their preparation and use
|
|
WO2005065183A2
(en)
|
2003-12-19 |
2005-07-21 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
US20080188527A1
(en)
|
2003-12-23 |
2008-08-07 |
Cashman John R |
Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer
|
|
TW200536830A
(en)
|
2004-02-06 |
2005-11-16 |
Chugai Pharmaceutical Co Ltd |
1-(2H)-isoquinolone derivative
|
|
WO2005115993A1
(ja)
|
2004-05-31 |
2005-12-08 |
Banyu Pharmaceutical Co., Ltd. |
キナゾリン誘導体
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
WO2006012577A2
(en)
|
2004-07-22 |
2006-02-02 |
Bayer Pharmaceuticals Corporation |
Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake
|
|
US20070218155A1
(en)
|
2004-08-20 |
2007-09-20 |
Kuhrts Eric H |
Methods and compositions for treating dyslipidaemia
|
|
US7846915B2
(en)
|
2004-10-20 |
2010-12-07 |
Resverlogix Corporation |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
US20080152595A1
(en)
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
JP2008526734A
(ja)
|
2004-12-31 |
2008-07-24 |
エスケー ケミカルズ カンパニー リミテッド |
糖尿及び肥満治療予防に有効なキナゾリン誘導体
|
|
CR9465A
(es)
|
2005-03-25 |
2008-06-19 |
Surface Logix Inc |
Compuestos mejorados farmacocineticamente
|
|
US20070004763A1
(en)
*
|
2005-06-10 |
2007-01-04 |
Nand Baindur |
Aminoquinoline and aminoquinazoline kinase modulators
|
|
US8410109B2
(en)
|
2005-07-29 |
2013-04-02 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
|
EP1944301A4
(en)
|
2005-10-27 |
2012-01-04 |
Msd Kk |
NEW BENZOXATHIIN DERIVATIVES
|
|
WO2007071055A1
(en)
|
2005-12-21 |
2007-06-28 |
Painceptor Pharma Corporation |
Compositions and methods for modulating gated ion channels
|
|
CA2621134C
(en)
|
2006-05-12 |
2011-07-26 |
Pharmathen S.A. |
Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
|
|
EP2079448A2
(en)
|
2006-10-10 |
2009-07-22 |
Dexcel Pharma Technologies Ltd. |
Improved release of statins in the intestine
|
|
US20080085911A1
(en)
|
2006-10-10 |
2008-04-10 |
Reliant Pharmaceuticals, Inc. |
Statin and omega-3 fatty acids for reduction of apo-b levels
|
|
WO2008059024A1
(en)
|
2006-11-15 |
2008-05-22 |
High Point Pharmaceuticals, Llc |
2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes
|
|
WO2008084483A1
(en)
*
|
2007-01-11 |
2008-07-17 |
Ramot At Tel Aviv University Ltd. |
Novel therapeutics based on tau/microtubule dynamics
|
|
MX2009008099A
(es)
|
2007-02-01 |
2009-12-14 |
Resverlogix Corp |
Compuestos para la prevencion y tratamiento de enfermedades cardiovasculares.
|
|
ES2308916B1
(es)
|
2007-03-22 |
2009-10-29 |
Consejo Superior De Investigaciones Cientificas |
Compuesto inhibidor dual de las enzimas pde7 y/o pde4, composiciones farmaceuticas y sus aplicaciones.
|
|
EP2005941A3
(de)
|
2007-06-01 |
2009-04-01 |
Henkel AG & Co. KGaA |
Zellverjüngende Zusammensetzungen
|
|
WO2008152471A1
(en)
|
2007-06-12 |
2008-12-18 |
Coley Pharmaceutical Group, Inc. |
Quinazoline derivative useful as toll-like receptor antagonist
|
|
EA201000003A1
(ru)
|
2007-06-21 |
2010-06-30 |
Айрм Ллк |
Ингибиторы протеинкиназ и способы их применения
|
|
EP2239264A4
(en)
|
2007-12-28 |
2012-01-11 |
Mitsubishi Tanabe Pharma Corp |
ANTITUMORAL MEDIUM
|
|
KR101629356B1
(ko)
|
2008-06-26 |
2016-06-13 |
리스버로직스 코퍼레이션 |
퀴나졸리논 유도체의 제조방법
|
|
EP2324022A1
(de)
|
2008-08-05 |
2011-05-25 |
Boehringer Ingelheim International GmbH |
Substituierte naphthyridine und ihre verwendung als arzneimittel
|
|
AU2009302473A1
(en)
|
2008-10-06 |
2010-04-15 |
Carolus Therapeutics, Inc. |
Methods of treating inflammation
|
|
CA2741934C
(en)
|
2008-10-30 |
2016-09-13 |
Circomed Llc |
Thienotriazolodiazepine derivatives active on apo a
|
|
US20100183598A1
(en)
|
2008-11-12 |
2010-07-22 |
Carolus Therapeutics, Inc. |
Methods of treating cardiovascular disorders
|
|
CA2747417C
(en)
|
2009-01-08 |
2017-01-03 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|
|
EP2403844A1
(en)
|
2009-03-06 |
2012-01-11 |
F. Hoffmann-La Roche AG |
Heterocyclic antiviral compounds
|
|
KR101913109B1
(ko)
|
2009-03-18 |
2018-10-31 |
리스버로직스 코퍼레이션 |
신규한 소염제
|
|
DK2421533T3
(en)
|
2009-04-22 |
2019-01-07 |
Resverlogix Corp |
Hitherto unknown anti-inflammatory agents
|
|
CN107233337A
(zh)
|
2009-04-29 |
2017-10-10 |
阿马里纳药物爱尔兰有限公司 |
含有epa和心血管剂的药物组合物以及使用其的方法
|
|
ES2353093B1
(es)
|
2009-05-20 |
2012-01-03 |
Consejo Superior De Investigaciones Científicas (Csic) |
Uso de derivados de quinazolinas y sus composiciones farmacéuticas en enfermedades neurodegenerativas.
|
|
GB201007286D0
(en)
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
|
DE102010048800A1
(de)
|
2010-10-20 |
2012-05-10 |
Merck Patent Gmbh |
Chinoxalinderivate
|
|
GB201018147D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Method of treatment
|
|
UA109797C2
(uk)
|
2010-11-05 |
2015-10-12 |
|
Спосіб боротьби з бур'янами, що мають стійкість до гербіцидів на основі феноксіалканових кислот, за допомогою 4-аміно-3-хлор-6-(4-хлор-2-фтор-3-метоксифеніл)піридин-2-карбонової кислоти і її солей або складних ефірів
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
JP2014505732A
(ja)
|
2011-02-16 |
2014-03-06 |
ピヴォタル セラピューティクス インコーポレイテッド |
心血管疾患において用いるための、スタチンおよびω３脂肪酸（ＥＰＡ、ＤＨＡおよびＤＰＡ）
|
|
US9328117B2
(en)
|
2011-06-17 |
2016-05-03 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
US20140227321A1
(en)
|
2011-09-30 |
2014-08-14 |
Kineta, Inc. |
Anti-viral compounds
|
|
LT2773354T
(lt)
*
|
2011-11-01 |
2019-08-12 |
Resverlogix Corp. |
Geriamosios greitai atsipalaiduojančios pakeistų chinozolinų vaisto formos
|
|
US20130281398A1
(en)
*
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281397A1
(en)
*
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US9624244B2
(en)
|
2012-06-06 |
2017-04-18 |
Constellation Pharmaceuticals, Inc. |
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
KR101532570B1
(ko)
|
2012-10-15 |
2015-06-30 |
리스버로직스 코퍼레이션 |
벤즈아미드 화합물의 합성에 유용한 화합물
|
|
NZ707115A
(en)
|
2012-10-15 |
2018-03-23 |
Albemarle Corp |
Processes for the synthesis of 2-amino-4,6-dimethoxybenzamide and other benzamide compounds
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
WO2014080291A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Biaryl derivatives as bromodomain inhibitors
|
|
WO2014096965A2
(en)
|
2012-12-21 |
2014-06-26 |
Rvx Therapeutics Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2014110090A1
(en)
|
2013-01-08 |
2014-07-17 |
Jerome Schentag |
Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systems
|
|
WO2014134583A2
(en)
|
2013-02-28 |
2014-09-04 |
Washington University |
Methods of treatment of human cytomegalovirus infection and diseases with bromodomain inhibitors
|
|
EP2970312B1
(en)
|
2013-03-11 |
2017-11-15 |
The Regents of The University of Michigan |
Bet bromodomain inhibitors and therapeutic methods using the same
|
|
CN105407894A
(zh)
|
2013-03-14 |
2016-03-16 |
康威基内有限公司 |
用于抑制含布罗莫结构域的蛋白质的方法和组合物
|
|
BR112015024116A2
(pt)
|
2013-03-27 |
2017-10-24 |
Hoffmann La Roche |
marcadores genéticos para prever capacidade de resposta à terapia
|
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域（ｂｒｏｍｏｄｏｍａｉｎ）抑制劑之苯並咪唑酮衍生物類
|
|
JP2016528275A
(ja)
|
2013-08-21 |
2016-09-15 |
レスバーロジックス コーポレイション |
プラーク退縮を促進するための組成物及び治療法
|
|
MX2016002178A
(es)
*
|
2013-08-21 |
2016-06-06 |
Resverlogix Corp |
Composiciones y metodos terapeuticos para la regresion acelerada de placa.
|
|
US9814728B2
(en)
|
2013-09-20 |
2017-11-14 |
Saint Louis University |
Inhibition of DUX4 expression using bromodomain and extra-terminal domain protein inhibitors (BETi)
|
|
US20170044127A1
(en)
|
2014-01-23 |
2017-02-16 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Icariin derivatives
|
|
JP6854752B2
(ja)
|
2014-07-30 |
2021-04-07 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｈｄｌ上昇剤又はｈｄｌ模倣剤を用いた治療に対する応答性を予測するための遺伝マーカー
|
|
WO2016123054A2
(en)
|
2015-01-26 |
2016-08-04 |
The University Of North Carolina At Chapel Hill |
Kinase drug combinations and methods of use thereof
|
|
US20180104232A1
(en)
|
2015-03-12 |
2018-04-19 |
The University Of Chicago |
Methods for determining prognosis for breast cancer patients
|
|
JP6903585B2
(ja)
|
2015-03-13 |
2021-07-14 |
レスバーロジックス コーポレイション |
補体関連疾患の治療のための組成物および治療方法
|
|
JP2018516884A
(ja)
|
2015-05-08 |
2018-06-28 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
コルチスタチン誘導体による治療に対する患者の標的化選択
|
|
US10702527B2
(en)
|
2015-06-12 |
2020-07-07 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
CN106265679A
(zh)
|
2015-06-28 |
2017-01-04 |
复旦大学 |
溴结构域蛋白抑制剂在制备抗hiv-1潜伏治疗药物中的用途
|
|
US9896663B2
(en)
|
2016-03-11 |
2018-02-20 |
Peter Maccallum Cancer Institute |
Leukaemia stem cell line, its method of production and uses thereof
|
|
CN106176753A
(zh)
|
2016-07-15 |
2016-12-07 |
南方医科大学 |
Rvx‑208作为hiv‑1潜伏感染逆转剂的应用
|
|
US10158038B1
(en)
*
|
2018-05-17 |
2018-12-18 |
Hi Llc |
Fast-gated photodetector architectures comprising dual voltage sources with a switch configuration
|